{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T05:06:12Z","timestamp":1780549572660,"version":"3.54.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Peptides"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1016\/j.peptides.2010.10.024","type":"journal-article","created":{"date-parts":[[2010,11,4]],"date-time":"2010-11-04T08:18:00Z","timestamp":1288858680000},"page":"293-299","source":"Crossref","is-referenced-by-count":12,"title":["Synthesis and antinociceptive effects of endomorphin-1 analogs with C-terminal linked by oligoarginine"],"prefix":"10.1016","volume":"32","author":[{"given":"Chang-lin","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-qing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-man","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.peptides.2010.10.024_bib0005","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal Biochem"},{"key":"10.1016\/j.peptides.2010.10.024_bib0010","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1126\/science.252.5009.1167","article-title":"Arginine-mediated RNA recognition: the arginine fork","volume":"252","author":"Calnan","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.peptides.2010.10.024_bib0015","doi-asserted-by":"crossref","first-page":"5423","DOI":"10.1523\/JNEUROSCI.22-13-05423.2002","article-title":"In vivo delivery of a Bcl-xL fusion protein containing the TAT protein transduction domain protects against ischemic brain injury and neuronal apoptosis","volume":"22","author":"Cao","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.peptides.2010.10.024_bib0020","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.regpep.2005.04.005","article-title":"Structure-activity studies on different modifications of nociceptin\/orphanin FQ: identification of highly potent agonists and antagonists of its receptor","volume":"130","author":"Chang","year":"2005","journal-title":"Regul Pept"},{"key":"10.1016\/j.peptides.2010.10.024_bib0025","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","article-title":"Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction","volume":"22","author":"Cheng","year":"1973","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.peptides.2010.10.024_bib0030","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1164\/ajrccm.162.3.9911102","article-title":"Differential cardiorespiratory effects of endomorphin 1, endomorphin 2, DAMGO, and morphine","volume":"162","author":"Czapla","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.peptides.2010.10.024_bib0035","doi-asserted-by":"crossref","first-page":"553","DOI":"10.2165\/00003088-200746070-00002","article-title":"Strategies to improve drug delivery across the blood\u2013brain barrier","volume":"46","author":"de Boer","year":"2007","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.peptides.2010.10.024_bib0040","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2174\/1567201052772843","article-title":"New prospects for glycopeptide based analgesia: glycoside-induced penetration of the blood\u2013brain barrier","volume":"2","author":"Dhanasekaran","year":"2005","journal-title":"Curr Drug Deliv"},{"key":"10.1016\/j.peptides.2010.10.024_bib0045","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S0022-3565(24)29218-1","article-title":"Improved blood\u2013brain barrier penetration and enhanced analgesia of an opioid peptide by glycosylation","volume":"299","author":"Egleton","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.peptides.2010.10.024_bib0050","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1124\/jpet.104.069393","article-title":"Antinociceptive structure-activity studies with enkephalin-based opioid glycopeptides","volume":"311","author":"Elmagbari","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.peptides.2010.10.024_bib0055","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1021\/bc060034h","article-title":"Intracellular delivery of proteins in complexes with oligoarginine-modified liposomes and the effect of oligoarginine length","volume":"17","author":"Furuhata","year":"2006","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.peptides.2010.10.024_bib0060","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/bip.20421","article-title":"Oligoarginine vectors for intracellular delivery: design and cellular-uptake mechanisms","volume":"84","author":"Futaki","year":"2006","journal-title":"Biopolymers"},{"key":"10.1016\/j.peptides.2010.10.024_bib0065","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/S0196-9781(99)00127-8","article-title":"The effect of halogenation on blood\u2013brain barrier permeability of a novel peptide drug","volume":"20","author":"Gentry","year":"1999","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2010.10.024_bib0070","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1476-5381.1957.tb01354.x","article-title":"Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse","volume":"12","author":"Haley","year":"1957","journal-title":"Br J Pharmacol Chemother"},{"key":"10.1016\/j.peptides.2010.10.024_bib0075","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1002\/jps.10202","article-title":"Effect of guanidino modification and proline substitution on the in vitro stability and blood\u2013brain barrier permeability of endomorphin II","volume":"91","author":"Hau","year":"2002","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.peptides.2010.10.024_bib0080","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1472-8206.1999.tb00316.x","article-title":"Drug transfer across the blood\u2013brain barrier and improvement of brain delivery","volume":"13","author":"Jolliet-Riant","year":"1999","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.peptides.2010.10.024_bib0085","doi-asserted-by":"crossref","first-page":"6713","DOI":"10.1016\/j.bmc.2005.07.051","article-title":"Synthesis and biological activity of N-methylated analogs of endomorphin-2","volume":"13","author":"Kruszynski","year":"2005","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.peptides.2010.10.024_bib0090","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1124\/jpet.106.106484","article-title":"Utilization of combined chemical modifications to enhance the blood\u2013brain barrier permeability and pharmacological activity of endomorphin-1","volume":"319","author":"Liu","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.peptides.2010.10.024_bib0095","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1038\/sj.bjp.0701971","article-title":"Glycodermorphins: opioid peptides with potent and prolonged analgesic activity and enhanced blood\u2013brain barrier penetration","volume":"124","author":"Negri","year":"1998","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.peptides.2010.10.024_bib0100","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1021\/jm9810699","article-title":"Dermorphin and deltorphin glycosylated analogues: synthesis and antinociceptive activity after systemic administration","volume":"42","author":"Negri","year":"1999","journal-title":"J Med Chem"},{"key":"10.1016\/j.peptides.2010.10.024_bib0105","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0167-7799(94)90123-6","article-title":"New approaches to drug delivery through the blood\u2013brain barrier","volume":"12","author":"Pardridge","year":"1994","journal-title":"Trends Biotechnol"},{"key":"10.1016\/j.peptides.2010.10.024_bib0110","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1007\/s11095-007-9303-7","article-title":"Cell penetrating peptides: intracellular pathways and pharmaceutical perspectives","volume":"24","author":"Patel","year":"2007","journal-title":"Pharm Res"},{"key":"10.1016\/j.peptides.2010.10.024_bib0115","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.peptides.2009.12.002","article-title":"Synthesis and biological evaluation of cyclic endomorphin-2 analogs","volume":"31","author":"Perlikowska","year":"2010","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2010.10.024_bib0120","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.neuroimage.2005.06.007","article-title":"Crossing the blood\u2013brain barrier: a potential application of myristoylated polyarginine for in vivo neuroimaging","volume":"28","author":"Pham","year":"2005","journal-title":"Neuroimage"},{"key":"10.1016\/j.peptides.2010.10.024_bib0125","doi-asserted-by":"crossref","first-page":"7114","DOI":"10.1073\/pnas.91.15.7114","article-title":"Glycopeptide enkephalin analogues produce analgesia in mice: evidence for penetration of the blood\u2013brain barrier","volume":"9","author":"Polt","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.peptides.2010.10.024_bib0130","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1749-6632.1999.tb07887.x","article-title":"Pain inhibition by endomorphins","volume":"897","author":"Przew\u0142ocki","year":"1999","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.peptides.2010.10.024_bib0135","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1124\/mol.57.4.679","article-title":"New advances in the transport of doxorubicin through the blood\u2013brain barrier by a peptide vector-mediated strategy","volume":"57","author":"Rousselle","year":"2000","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.peptides.2010.10.024_bib0140","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1124\/jpet.102.048520","article-title":"Improved brain uptake and pharmacological activity of dalargin using a peptide-vector-mediated strategy","volume":"306","author":"Rousselle","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.peptides.2010.10.024_bib0145","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1080\/10611860290031886","article-title":"Improved brain delivery of benzylpenicillin with a peptide-vector-mediated strategy","volume":"10","author":"Rousselle","year":"2002","journal-title":"J Drug Target"},{"key":"10.1016\/j.peptides.2010.10.024_bib0150","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0022-3565(24)29672-5","article-title":"Enhanced delivery of doxorubicin into the brain via a peptide-vector-mediated strategy: saturation kinetics and specificity","volume":"296","author":"Rousselle","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.peptides.2010.10.024_bib0155","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/S0022-5347(25)00367-2","article-title":"Pharmacologic evaluation of a cyclic somatostatin analog with antagonist activity at mu opioid receptors in vitro","volume":"240","author":"Shook","year":"1987","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.peptides.2010.10.024_bib0160","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1471-4159.1986.tb13027.x","article-title":"Kinetics and physical parameters of rat brain opioid receptors solubilized by digitonin and CHAPS","volume":"46","author":"Simon","year":"1986","journal-title":"J Neurochem"},{"key":"10.1016\/j.peptides.2010.10.024_bib0165","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0014-2999(03)01736-9","article-title":"Antinociception by a peripherally administered novel endomorphin-1 analogue containing beta-proline","volume":"469","author":"Spampinato","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.peptides.2010.10.024_bib0170","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1517\/14712598.1.5.773","article-title":"Vector-mediated drug delivery to the brain","volume":"1","author":"Temsamani","year":"2001","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.peptides.2010.10.024_bib0175","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S1461-5347(00)00258-3","article-title":"Brain drug delivery technologies: novel approaches for transporting therapeutics","volume":"3","author":"Temsamani","year":"2000","journal-title":"Pharm Sci Technol Today"},{"key":"10.1016\/j.peptides.2010.10.024_bib0180","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/S1359-6446(04)03279-9","article-title":"The use of cell-penetrating peptides for drug delivery","volume":"9","author":"Temsamani","year":"2004","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.peptides.2010.10.024_bib0185","doi-asserted-by":"crossref","first-page":"6415","DOI":"10.1016\/j.bmc.2008.05.001","article-title":"Structure-activity study of endomorphin-2 analogs with C-terminal modifications by NMR spectroscopy and molecular modeling","volume":"16","author":"Wang","year":"2008","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.peptides.2010.10.024_bib0190","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1016\/S0196-9781(00)00340-5","article-title":"Dissociation of analgesic and rewarding effects of endomorphin-1 in rats","volume":"21","author":"Wilson","year":"2002","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2010.10.024_bib0195","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/S0196-9781(01)00537-X","article-title":"Peptide drug modifications to enhance bioavailability and blood\u2013brain barrier permeability","volume":"22","author":"Witt","year":"2001","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2010.10.024_bib0200","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/jbm.a.31331","article-title":"Intracellular delivery enhancement of poly(amino acid) drug carriers by oligoarginine conjugation","volume":"86","author":"Yang","year":"2008","journal-title":"J Biomed Mater Res A"},{"key":"10.1016\/j.peptides.2010.10.024_bib0205","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/cmdc.200600274","article-title":"Structure-activity study on the spatial arrangement of the third aromatic ring of endomorphins 1 and 2 using an atypical constrained C terminus","volume":"2","author":"Yu","year":"2007","journal-title":"ChemMedChem"},{"key":"10.1016\/j.peptides.2010.10.024_bib0210","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/386499a0","article-title":"A potent and selective endogenous agonist for the mu-opiate receptor","volume":"386","author":"Zadina","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.peptides.2010.10.024_bib0215","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0006-291X(03)01167-7","article-title":"Quantitative comparison of membrane transduction and endocytosis of oligopeptides","volume":"307","author":"Zaro","year":"2003","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978110004778?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978110004778?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T15:49:27Z","timestamp":1740671367000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196978110004778"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["S0196978110004778"],"URL":"https:\/\/doi.org\/10.1016\/j.peptides.2010.10.024","relation":{},"ISSN":["0196-9781"],"issn-type":[{"value":"0196-9781","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]}}}